Evaluation of Soluble CD48 Levels in Patients with Allergic and Nonallergic Asthma in Relation to Markers of Type 2 and Non-Type 2 Immunity: An Observational Study

Table 2

sCD48, type 2 biomarkers, and cytokine levels according to patient categorization (see also Figure 1).

	Allergic asthma ()	Nonallergic asthma ()	Control ()	ANOVA value
sCD48 (pg/ml)	1358 (1228–1632)	1487 (1338–1758)	1308 (1070–1581)	0.007
IgE (IU)	374.5 (233.8–781.5)	45.5 (18.25–74.15)	40 (17.5–72.1)	<0.0001
Eos count	400 (250–550)	150 (100–250)	175 (100–250)	<0.0001
IL5 (pg/ml)	2.746 (2.31–3.51)	2.434 (1.68–3.06)	2.395 (1.52–2.86)	0.009
IL17A (pg/ml)	84.44 (39.97–141.6)	115.5 (56.8–187.3)	56.7 (29.28–84.07)	<0.0001
IL33 (pg/ml)	130.3 (49.46–267.5)	154.9 (63.58–271.9)	54 (25.73–83.78)	< 0.0001
IFNg (pg/ml)	5.475 (3.19–13.05)	5.338 (3.47–10.68)	1.768 (1.18–3.2)	0.008

Data is presented as median (IQR); , , and .